100 Basis Points?

Zacks
Pan American Silver (PAAS) Reports Q2 Loss, Lags Revenue Estimates
Pan American Silver (PAAS) delivered earnings and revenue surprises of -121.43% and 16.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
15h ago
Simply Wall St.
These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
4h ago
GuruFocus.com
NIO: Mounting Headwinds Batter Investor Confidence
Persistent supply issues have deflated expectations for the Chinese automaker
19h ago
TipRanks
Elon Musk Says Lithium Demand Will Continue to Boom — Here Are 2 Stocks That Could Benefit
Let’s talk about electric vehicles (EVs) and their batteries. The high price of gasoline – still up about $2 since President Biden took office – has boosted interest in EVs. Greater customer curiosity will lead naturally to higher demand, and now we get to batteries, and lithium. Lithium is a metallic element essential in the construction of high-voltage battery systems, and every EV built needs an average of 8 kilos of the metal. Industry experts are saying that lithium demand will far outstrip
1h ago
TipRanks
‘Load Up,’ Says Jim Cramer About These 2 ‘Strong Buy’ Stocks
The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris
2d ago
Motley Fool
Is Beyond Meat Stock a Buy?
The plant-based meat producer's revenue declined 2% year over year to $147 million, missing analysts' estimates by $2 million. Beyond Meat isn't down for the count, but major setbacks have made it an easy target for the short sellers.
4h ago
Motley Fool
3 Reasons to Buy the Dip on Palantir
The mercurial stock is down after earnings, but there is still plenty of reason for optimism for long-term investors.
5h ago
TheStreet.com
Pfizer Stock Slumps Amid Litigation Concerns Linked to Zantac Heartburn Drug
Zantac, also sold as ranitidine, was pulled from the market in 2020 following a study that suggested it contained a cancer-causing impurity.
32m ago
Motley Fool
2 Stock-Split Stocks That Have Never Been Cheaper and 1 Value Trap to Avoid Like the Plague
Among the dozens of stocks to enact splits this year are two industry leaders that scream value and one cash-rich company that's clobbering its shareholders.
5h ago
Motley Fool
Verizon's Wireless Problem May Be Bigger Than You Think
Like the telecom industry's other two stalwarts, it wasn't ready for this new competition that didn't exist a few years ago.
5h ago
Motley Fool
Tesla's Stock Split Was Approved. What Does That Mean for Investors?
Smart investors shouldn't be concerned about stock splits. Instead, they should concentrate on a company's fundamentals.
3h ago
Simply Wall St.
Downgrade: Here's How Analysts See Vertex Energy, Inc. (NASDAQ:VTNR) Performing In The Near Term
The latest analyst coverage could presage a bad day for Vertex Energy, Inc. ( NASDAQ:VTNR ), with the analysts making...
4h ago
Simply Wall St.
Investors bid Axsome Therapeutics (NASDAQ:AXSM) up US$448m despite increasing losses YoY, taking five-year CAGR to 57%
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...
3h ago
Zacks
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
Senseonics (SENS) delivered earnings and revenue surprises of 25% and 12.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
2d ago
Motley Fool
3 Top Tech Stocks to Buy During a Recession
Choosing stocks that can weather the storm and do well afterward, too, are the kinds of companies we should seek out, and the following trio of top tech stocks should outperform no matter what the market throws at it. Having shed its Warner Media division into the newly reconstituted Warner Bros Discovery in April, AT&T (NYSE: T) is now able to focus solely on its telecom operations and the rollout of its 5G network that will provide the industry with its next wave of growth. Although AT&T says it's not immune from the recessionary impacts affecting the broader economy, it's capable of managing through them and investing for the long-term benefit of customers and investors.
4h ago
Yahoo Finance Video
Inflation: Falling energy prices ‘might be a sign of what’s more to come,’ strategist says
iCapital Chief Investment Strategist Anastasia Amoroso joins Yahoo Finance Live to discuss U.S. PPI data, how the energy market may foreshadow what's next, the crypto market outlook, and investor sentiment.
1h ago
Simply Wall St.
Fazal Merchant Is The Independent Director of Warner Bros. Discovery, Inc. (NASDAQ:WBD) And They Just Picked Up 217% More Shares
Potential Warner Bros. Discovery, Inc. ( NASDAQ:WBD ) shareholders may wish to note that the Independent Director...
5h ago
Zacks
What Awaits ZIM Integrated Shipping (ZIM) in Q2 Earnings?
High fuel costs might have hurt the Q2 bottom-line performance of ZIM Integrated Shipping (ZIM).
21h ago
Zacks
Lithium Likely to Become a De-Facto Precious Metal: 5 Picks
We have narrowed our search to five lithium producers. These are: ALB, LTHM, PLL, LAC and SQM.
1d ago
CNW Group
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit
Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court of Delaware has issued a decision in the matter of Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. finding certain XIFAXAN® (rifaximin) 550 mg HE patents valid and infringed and certain XIFAXAN composition and IBS-D patents invalid. As previously stated, the Company will
17h ago

S&P 500

Dow 30

Nasdaq

Russell 2000

Crude Oil

Gold

Silver

EUR/USD

10-Yr Bond

GBP/USD

USD/JPY

BTC-USD

CMC Crypto 200

FTSE 100

Nikkei 225

100 Basis Points?

Recommended Stories

Pan American Silver (PAAS) Reports Q2 Loss, Lags Revenue Estimates

These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts

NIO: Mounting Headwinds Batter Investor Confidence

Elon Musk Says Lithium Demand Will Continue to Boom — Here Are 2 Stocks That Could Benefit

‘Load Up,’ Says Jim Cramer About These 2 ‘Strong Buy’ Stocks

Is Beyond Meat Stock a Buy?

3 Reasons to Buy the Dip on Palantir

Pfizer Stock Slumps Amid Litigation Concerns Linked to Zantac Heartburn Drug

2 Stock-Split Stocks That Have Never Been Cheaper and 1 Value Trap to Avoid Like the Plague

Verizon's Wireless Problem May Be Bigger Than You Think

Tesla's Stock Split Was Approved. What Does That Mean for Investors?

Downgrade: Here's How Analysts See Vertex Energy, Inc. (NASDAQ:VTNR) Performing In The Near Term

Investors bid Axsome Therapeutics (NASDAQ:AXSM) up US$448m despite increasing losses YoY, taking five-year CAGR to 57%

Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates

3 Top Tech Stocks to Buy During a Recession

Inflation: Falling energy prices ‘might be a sign of what’s more to come,’ strategist says

Fazal Merchant Is The Independent Director of Warner Bros. Discovery, Inc. (NASDAQ:WBD) And They Just Picked Up 217% More Shares

What Awaits ZIM Integrated Shipping (ZIM) in Q2 Earnings?

Lithium Likely to Become a De-Facto Precious Metal: 5 Picks

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit